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High consumption of polyunsaturated fatty acids, such as sunflower oil has been associated to beneficial eﬀects in plasma lipid
profile, but its role on inflammation and insulin resistance is not fully elucidated yet. We evaluated the eﬀect of sunflower oil
supplementation on inflammatory state and insulin resistance condition in HFD-induced obese mice. C57BL/6 male mice (8
weeks) were divided in four groups: (a) control diet (CD), (b) HFD, (c) CD supplemented with n-6 (CD + n-6), and (d) HFD
supplemented with n-6 (HFD + n-6). CD + n-6 and HFD + n-6 were supplemented with sunflower oil by oral gavage at 2 g/Kg
of body weight, three times per week. CD and HFD were supplemented with water instead at the same dose. HFD induced whole
and muscle-specific insulin resistance associated with increased inflammatory markers in insulin-sensitive tissues and macrophage
cells. Sunflower oil supplementation was not eﬃcient in preventing or reducing these parameters. In addition, the supplementation
increased pro-inflammatory cytokine production by macrophages and tissues. Lipid profile, on the other hand, was improved with
the sunflower oil supplementation in animals fed HFD. In conclusion, sunflower oil supplementation improves lipid profile, but it
does not prevent or attenuate insulin resistance and inflammation induced by HFD in C57BL/6 mice.
1. Introduction
Occidental diet is characterized by high caloric intake, mainly
saturated fatty acids and glucose consumption, contributing
to the development of obesity and insulin resistance. In
the past 15 years, obesity has been associated to chronic
inflammation in several tissues and cells, such as liver,
adipose tissue, skeletal muscle, and immune cells.
In fact, chronic and subclinical “low-grade” inflamma-
tory state is a hallmark of obesity, and this condition has
been proposed to play a central role in the development
of insulin resistance, type 2 diabetes mellitus, and steatosis
[1]. During the past decades, the prevalence of obesity has
enormously increased worldwide [2]. A possible interaction
factor between metabolic disorders and inflammation is the
disruption in lipid metabolism caused by high levels of
saturated fatty acids from high-fat and caloric diet [3, 4].
C57BL/6 mice develop obesity, insulin resistance (IR),
diabetes mellitus, advanced fatty liver, and fatty pancreatic
diseases when submitted to a high-fat diet (HFD), mainly
enriched with saturated fatty acids [5]. The composition
of fatty acids on diet can be an important modulator
of lipid metabolism and inflammation. Some studies have
showed that an increase in circulating levels of mono- or
polyunsaturated fatty acids improves insulin sensitivity and
ameliorates hepatic steatosis [6, 7]. Sunflower oil is rich in
2 Journal of Biomedicine and Biotechnology
mono- (MUFA) and polyunsaturated fatty acids (PUFA),
mainly linoleic acid, a member of the n-6 family.
Diet enriched with sunflower oil decreases plasma
triacylglycerol and has beneficial eﬀects on plasma lipid
profile [8]. Moreover, acute administration of sunflower
oil in rats potentially prevents the gastric damages gen-
erated by indomethacin administration through increased
anti-inflammatory response [9]. However, mice fed with
sunflower oil-enriched diet present increased IL-6 (a pro-
inflammatory cytokine) levels in white adipose tissue[8].
Thus, further studies are required to adequately determine
the pro- or anti-inflammatory eﬀects of n-6 fatty acids.
Adipose tissue, skeletal muscle, liver, and immune cells
have been identified as critical targets for the disruption
in metabolic and inflammatory signaling in obesity. The
imbalance between metabolic alterations and inflammatory
signaling pathways leads to insulin resistance, hepatic steato-
sis, and related diseases [4, 10].
In this study, we evaluated the eﬀect of sunflower oil
supplementation on inflammation and insulin sensitivity in
mice fed a balanced diet and a HFD (rich in saturated fatty
acids). The protecting or potentiating eﬀect of sunflower oil
supplementation on insulin resistance and inflammation was
investigated. Whole body (Insulin Tolerance Test—ITT and
Glucose Tolerance Test—GTT) and skeletal muscle (glucose
uptake and metabolism) insulin sensitivity was examined.
Inflammatory markers were investigated in liver, adipose
tissue, skeletal muscle, and peritoneal macrophages. The
strategy used was to investigate the eﬀect of sunflower oil
supplementation in mice fed a balanced diet and a HFD.
Under this last condition, a clear inflammatory state is
established and so a possible anti-inflammatory eﬀect could
be pronounced.
2. Materials and Methods
2.1. Animals. All animal studies were performed according
to protocols approved by the Animal Care and Use Commit-
tee from the Institute of Biomedical Sciences, University of
Sa˜o Paulo. C57BL/6 male mice (8 weeks-old) were used for
the study. Animals were housed in a room with light-dark
cycle of 12-12 h and temperature of 23 ± 2◦C. Animals were
divided in four groups: (a) control diet (CD), (b) high-fat
diet (HFD), (c) control diet supplemented with n-6 (CD +
n-6), and (d) high-fat diet supplemented with n-6 (HFD +
n-6). During the first 4 weeks preceding the induction of
obesity by HFD, all the four experimental groups were fed ad
libitum with a control diet (76% carbohydrates, 9% fat, 15%
proteins). CD + n-6 and HFD + n-6 were supplemented with
sunflower oil (n-6 PUFA source) by oral gavage at 2 g per
Kg of body weight, three times per week, during 12 weeks.
This dosage of oil was chosen based on previous studies using
diﬀerent oils from our group and others [11–13]. CD and
HFD received water at the same dose.
2.2. HFD-Induced Obesity and Insulin Resistance. After the
first 4 weeks, animals from the HFD and HFD + n-6 groups
received high-fat diet (26% carbohydrates, 59% fat, 15%
proteins) during the next 8 weeks. CD and CD + n-6 groups
remained on the control diet. Supplementation with n-6
(sunflower oil, 2 g/Kg b.w.) was kept until the end of the 12
weeks.
2.3. Glucose and Insulin Tolerance Tests. Tolerances to glucose
(GTT) and to insulin (ITT) were evaluated after 6 h fasting.
For GTT, mice were intraperitoneally injected (i.p.) with
glucose (2 g/Kg body weight). Blood glucose measurements
were performed at 0, 15, 30, 45, 60, and 90min after
glucose injection. Glucose concentration versus time was
plotted and the area under the curve (AUC) was calculated
for each animal. For ITT, animals were i.p. injected with
insulin (Humulin R, Lilly, 0.75UI/kg b.w.) and glucose
measurements were performed at 0, 10, 20, 30, 40, 50, and
60min after injection. Glucose concentration versus time
was plotted and the glucose lowering rate was calculated.
In both tests, blood samples were collected from the tail
vein. For GTT, serum glucose was measured by colorimet-
ric assay commercially available (PAP Liquiform Glucose,
Labtest) and for ITT, glucose was measured by using
glucometer (One Touch Ultra, Johnson & Johnson).
2.4. Serum Parameters Analysis. After 6 hours fasting, ani-
mals were anesthetized and blood was collected by punc-
turing the orbital plexus. Serum glucose, triacylglycerol,
total cholesterol, LDL-cholesterol, andHDL-cholesterol were
determined by colorimetric assays (Labtest Diagnostics,
Lagoa Santa, MG, Brazil).
2.5. Responsiveness to Insulin in Isolated Soleus Muscle.
Animals were euthanized by cervical dislocation and soleus
muscles rapidly and carefully isolated, weighed (8–10mg),
attached to stainless steel clips to maintain resting tension,
and preincubated for 30min, at 37◦C, in Krebs-Ringer bicar-
bonate buﬀer (KRBB) containing 5.6mM glucose and 1%
bovine serum albumin (BSA), pH 7.4, pregassed for 30min
with 95% O2/5% CO2, with agitation at 100 oscillations per
min. After this period, muscles were transferred to other vials
containing the same buﬀer, but added of 0.3 μCi/mL D-[U-
14C]-glucose and 0.2 μCi/mL 2-deoxy-D-[2,6-3H]-glucose.
Phenylethylamine (0.2mL), diluted 1 : 1 v/v inmethanol, was
added into a separate compartment for 14CO2 adsorption.
Incubation was then performed for 1 h under similar condi-
tions, in the absence or presence of 7 nM insulin. Gasification
with 95% O2/5% CO2 was maintained during the pre-
incubation and the first 15min of the incubation period and
then stopped.
After the incubation period, muscles were briefly washed
in cold KRBB at 4◦C, dried on filter paper and frozen
in liquid N2. Samples were processed for measurements
of uptake of 2-deoxy-D-[2,6-3H]-glucose, D-[14C]-glucose
incorporation, [14C]-glycogen synthesis, and decarboxyla-
tion of D-[14C]-glucose, according to methods described by
Challiss et al. [14], Espinal et al. [15] and Leighton et al.
[16], respectively, and routinely have been used by our group
[11, 17–22].
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Table 1: Obesity characteristics from mice fed with control diet (CD) or high-fat diet (HFD), supplemented or not with sunflower oil (rich
in n-6 fatty acids).
CD HFD CD+n6 HFD+n6
Body weight gain (g) 2.90 ± 0.42 11.30± 0.91∗ 3.99 ± 0.65 10.33 ± 0.50#
Food ingestion (g/day/animal) 3.61 ± 0.091 2.44± 0.164∗ 4.53 ± 0.158∗ 2.45 ± 0.033#
Food eﬃciency (body weight gain (g)/food ingestion (g)) 0.014 ± 0.06 0.083± 0.022∗ 0.016 ± 0.008 0.075 ± 0.011#
Epididymal adipose tissue (mg) 737.9 ± 89.4 1777.0± 234.3∗ 555.1 ± 45.5 1450.0 ± 176.8#
Oral supplementation with sunflower oil rich in n-6 (2 g/Kg body weight, three times a week, oral gavage) or water, started four weeks before feeding or not
with HFD, maintained until the end of experimental protocol. Animals were feed with HFD or CD for additional eight weeks. Mean ± SEM (n = 8–10). Data
were analyzed by two-way ANOVA and Bonferroni post-test. ∗P < 0.05 versus CD; #P < 0.05 versus CD + n6.
2.6. Analysis of Inflammatory Parameters
2.6.1. Tissue Cytokine and Adipokine Content Measurements.
Mice were euthanized on CO2 chamber and visceral adipose
tissue (epididymal, retroperitoneal, and mesenteric), liver,
gastrocnemius muscle, and peritoneal macrophages rapidly
collected. About 100mg of liver, gastrocnemius muscle and
retroperitoneal adipose tissue were used for the determi-
nation of TNF-α, IL-6, and IL-10 content. Tissues were
homogenized in RIPA buﬀer (0.625% Nonidet P-40, 0.625%
sodium deoxycholate, 6.25mM sodium phosphate, and
1mM ethylenediamine tetra acetic acid at pH 7.4), contain-
ing 10 g/mL of a protease inhibitor cocktail (Sigma-Aldrich,
St. Louis, MO, USA). Homogenates were centrifuged at
12,000 g for 10min at 4◦C, supernatant was collected, and
protein concentration determined using Bradford assay (Bio-
Rad, Hercules, CA, USA). Bovine serum albumin was used
as a protein reference. Likewise, about 150mg of epididymal
adipose tissue were cultured in DMEM sterile medium
(Gibco), containing 10% FBS, 2mM glutamine and antibi-
otics for 24 h, at 37◦C, 5% CO2 humidified air environment.
Thereafter, medium culture was collected and used for the
determination of leptin, adiponectin, and resistin contents.
For all determinations, we used colorimetric immunoassays
ELISA (DuoSet kits, R&D System).
2.6.2. Peritoneal Macrophage Isolation and Culture. Cytokine
and nitric oxide (NO) production was evaluated in
macrophages obtained by washing the peritoneal cavity with
6mL RPMI culture medium (Gibco), containing 10% FBS
and 4mM glutamine. Macrophage-rich cultures (more than
90% of the cells were F4/80+) were obtained by incubating
peritoneal cells in 24-well polystyrene culture plates for
2 h at 37◦C in a 5% CO2, humidified air environment.
Nonadherent cells were removed by washing with RPMI.
Adherent cells were then incubated with 2.5 μg/mL of LPS
(E. coli, serotype 0111:B4, Sigma Chemical Company, USA)
for 24 h [23]. Medium was collected for determination of IL-
6, IL-10, and TNF-α by ELISA, and nitrite content by Griess
method [24].
2.7. Statistical Analysis. Data are presented as mean ± SEM.
All groups were compared by two-way ANOVA following
Bonferroni posttests. P < 0.05 was considered to be
significant.
3. Results
3.1. Exposure to HFD Induces Obesity Associated with Glucose
and Insulin Intolerance. Animals fed with HFD for eight
weeks showed increased (by 3.8 fold) body weight gain
when compared to those fed with CD. Despite reduced food
ingestion, the food eﬃciency of HFD was 6 fold higher than
CD. Moreover, epididymal adipose tissues were increased by
HFD. Sunflower oil did not change body weight gain, food
eﬃciency, or adipose tissue increased (Table 1).
HFD increased fasted glucose in 18% (Table 2). An
increase of 63% in area under the curve in glucose tolerance
test (GTT) was also observed in animals treated with HDF,
demonstrating glucose intolerance, which was associated
with insulin intolerance, as observed by the reduction in
glucose clearance during insulin tolerance test (ITT). Sup-
plementation with sunflower oil maintained fasted glucose
levels similar to CD. However, the supplementation did not
prevent the glucose and insulin intolerance induced by HFD.
Furthermore, sunflower oil supplementation induced insulin
intolerance itself (CD + n-6 group), reducing the clearance
of glucose similar to HFD without supplementation. Total
cholesterol and LDL cholesterol levels were increased byHFD
and sunflower oil supplementation in association with HFD
showed protective eﬀect in the prevention of the increased
LDL cholesterol and cholesterol total levels found in HFD.
3.2. HFD Impaired Glucose Uptake and Metabolism in Soleus
Muscle. Soleus muscles from animals fed with HFD did
not respond to insulin stimulus in relation to glucose
uptake and metabolism (Figure 1), characterizing muscle
insulin resistance state. This eﬀect was not prevented or
reduced by sunflower oil supplementation. Interestingly, the
supplementation itself (CD + n-6 group) increased basal
glucose uptake and glucose oxidation, but it failed to respond
to the insulin stimulus when compared to the control group
(CD group).
3.3. HFD and Sunflower Oil Supplementation Induced
Inflammation. Peritoneal macrophages stimulated with LPS
showed increased production of nitrite, TNFα, IL6, and
IL10 when compared with unstimulated cells (Figure 2).
Macrophages from animals with obesity induced by HFD
for 8 weeks showed a inflammatory profile, with increased
production of nitrite, TNF-α, and IL-6, associated with
decreased content of IL-10 when stimulated with LPS.
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Table 2: Metabolic parameters from mice fed with control diet (CD) or high-fat diet (HFD), supplemented, or not with sunflower oil (rich
in n-6 fatty acids).
CD HFD CD + n6 HFD + n6
Fasted glucose (mg/dL) 186.1 ± 5.66 221.0± 8.38∗ 173.8 ± 4.75 196.8 ± 10.66
GTT test (AUC) 7987 ± 779.3 13090± 643.9∗ 7568 ± 1359 14790 ± 1731#
ITT test (% glucose/min) 2.97 ± 0.19 2.13± 0.21∗ 1.94± 0.30∗ 1.98 ± 0.22
Total cholesterol (mg/dL) 148.2 ± 6.72 192.7± 11.96∗ 164.3 ± 14.00 166.3 ± 12.33
LDL cholesterol (mg/dL) 127.4 ± 5.15 165.1± 14.49∗ 128.2 ± 13.77 136.7 ± 13.22
HDL cholesterol (mg/dL) 14.73 ± 0.83 15.52 ± 1.86 19.33 ± 2.21 15.00 ± 1.15
Triglycerides (mg/dL) 68.61 ± 5.56 63.00 ± 4.40 84.70 ± 8.53 72.78 ± 8.71
Oral supplementation with n-6 (2 g/Kg body weight, three times a week, gavage) or water have started four weeks before HFD and continued until the end of
experimental period. Animals were fed HFD or CD for eight weeks. GTT: glucose tolerance test; ITT: insulin tolerance test. Mean ± SEM (n = 6–15). ANOVA
two-way with Bonferroni post tests. ∗P < 0.05 when compared with CD; #P < 0.05 when compared with CD + n6.
Table 3: Adipokine production in adipose tissue from mice fed with control diet (CD) or high-fat diet (HFD), supplemented, or not with
sunflower oil (rich in n-6 fatty acids).
CD HFD CD+n6 HFD+n6
Epididymal adipose tissuea
Leptin 42.51 ± 8.75 81.38± 9.90∗ 62.42 ± 8.80 88.03 ± 10.96
Adiponectin 659.9 ± 39.94 697.6 ± 43.85 730.3 ± 76.68 649.8 ± 45.38
Resistin 625.1 ± 100.8 528.6 ± 71.65 913.0 ± 181.0 327.0 ± 42.15#
Oral supplementation with n-6 (2 g/Kg body weight, three times a week, gavage) or water started four weeks before HFD and continued until the end
of experiment. Animals were feed with HFD or CD for eight weeks. Approximately 150mg of tissue were incubated in DMEM medium for 24 h and the
supernatant were used for measures. Mean ± SEM (n = 7–11). ANOVA two-way with Bonferroni post tests. ∗P < 0.05 when compared with CD; #P < 0.05
when compared with CD+n6. aValues are expressed as pg/mL/mg tissue.
Interestingly, supplementation with sunflower oil induced
similar inflammatory response in macrophages. For TNF-
α only, the association of HFD and n-6 supplementation
(HFD + n-6 group) showed beneficial response, decreasing
this cytokine production.
In general, HFD induced and increase in the pro-
inflammatory cytokine IL6 and decrease in the anti-
inflammatory cytokine IL10 contents in the insulin target
tissues (liver, skeletal muscle, and adipose tissue; Figure 3).
Interesting, sunflower oil supplementation itself (CD +
n-6 group) for 12 weeks increased the content of the
proinflammatory cytokine IL6 in all tissues. However, when
the sunflower oil was associated with HFD (HFD + n-6
group), cytokine concentrations were similar to that found
in the HFD group, in liver and adipose tissue.
Adipokines production by epididymal adipose tissue was
determined after 24 h culture. Adipose tissues from HFD
animals showed increased production of leptin (Table 3).
Resistin was reduced only when HFD was associated to
sunflower oil supplementation (HFD + n-6 group) in
comparison to CD + n6 group.
4. Discussion
This is the first study to investigate the eﬀects of sunflower
oil supplementation on inflammation and insulin sensitivity
in mice fed a balanced diet and a HFD. We showed that
HFD induces decreased glucose tolerance (as demonstrated
by GTT) and insulin sensitivity (as observed in ITT) in the
whole body. Surprisingly, this last eﬀect was also verified in
the CD + n6 group. Moreover, proinflammatory response
was increased in the HFD group without prevention or atten-
uation by sunflower oil supplementation. This eﬀect was also
observed in CD + n6 group. Lipid profile was impaired by
HFD. Animals from HFD group showed an increase in total
and LDL cholesterol plasma levels. These alterations were
ameliorated by sunflower oil supplementation (HFD + n6
group).
HFD has been associated with insulin resistance and
inflammatory condition, contributing to the development
of several related diseases, such as obesity, diabetes mellitus
type 2, metabolic syndrome, cancer, and cardiovascular
diseases [25–27]. Various strategies have been investigated
in order to decreasing insulin resistance and inflammation,
including natural and modified compounds, cyclooxygenase
inhibitors, and physical exercise [28–35]. Since skeletal
muscle tissue represents 50–60% of the body weight and it
is the main insulin-responsive tissue in association to liver
and adipose tissue, it has been proposed that skeletal mus-
cle dysfunctions (reduced oxidative capacity and impaired
insulin sensitivity) play a central role in the abnormalities of
chronic diseases [21, 36–40]. In this work, we investigated the
eﬀect of sunflower oil supplementation on insulin sensitivity
(in whole animal in vivo and in soleus muscle in vivo)
and inflammatory condition (liver, skeletal muscle, adipose
tissue) in mice fed a balanced diet and a HFD. In recent
study, Bjermo et al. [41] showed that isocaloric diet with n-6
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Figure 1: Eﬀect of sunflower oil supplementation (rich in n-6 fatty acids) on glucose uptake and metabolism in isolated soleus muscle
from C57BL/6 mice. The muscles were incubated in Krebs Ringer buﬀer, containing 5.6mM glucose, 0.3 μCi/mL of [U-14C]-D-glucose and
0.2 μCi/mL of 2-deoxy-[2,6-3H]-D-glucose, in the absence (white bars) or presence (black bars) of 7 nM insulin, for one hour. At the end of
the incubation period, muscles were proceeded to analyze glucose uptake and metabolism as described in Materials and Methods. Results
are presented as mean ± SEM (n = 10–16). Two-way ANOVA and Bonferroni posttest were used for statistical analysis. §P < 0.05 versus the
insulin stimulated (+insulin) of the same group; ∗P < 0.05 versus CD with insulin; #P < 0.05 versus CD + n6 with insulin.
PUFA for 10 weeks reduce liver fat and modestly improves
metabolic conditions, without weight loss in humans. In
addition, it has been proposed that n-6 PUFA reduce risks
of cardiovascular diseases, by improving lipid profile [42].
This improvement in lipid profile was found in our study,
whereas HFD + n6 group showed decreased plasma LDL and
total cholesterol levels.
Some studies have shown that n-6 PUFA intake posi-
tively correlate with obesity and insulin resistance [43, 44].
Treatment with subcutaneous injection of sunflower oil by 7
days in Wistar rats impaired insulin sensitivity by decreasing
glucose clearance during ITT and GLUT-4 expression and
translocation in white adipose tissue (WAT), with no eﬀect
in skeletal muscle [7]. In the CD + n6 group, KiTT was
reduced, but glucose uptake and metabolism in isolated
soleus muscles were not altered after insulin stimulus. These
results suggest that sunflower oil supplementation per se is
not able to impair insulin response in skeletal muscle, but
it possibly reduces total insulin sensitivity by decreasing the
response to the hormone in other tissues, such as liver and
adipose tissue. This proposition has to be investigated in
further studies. In addition, both groups fed with HDF (HFD
and HFD + n6 groups) showed skeletal muscle resistance
to insulin, showing no beneficial eﬀects of n-6 PUFA on
peripheral insulin sensitivity.
Obesity is accompanied by a chronic low grade subclini-
cal inflammation promoted by an increase in fuel availability,
leading to infiltration of macrophages into adipose tissue.
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Figure 2: Nitric oxide and cytokine production in peritoneal macrophages collected from mice fed with control diet (CD) or high-fat diet
(HFD), supplemented or not with sunflower oil (rich in n-6 fatty acids, 2 g/Kg b.w., three times a week, by oral gavage). Animals were fed
with HFD or CD for eight weeks. Peritoneal macrophages were collected and cultured for 24 h in the absence (white bars) or presence (black
bars) of 2.5 μg/mL LPS. Nitric oxide (a), TNF-α (b), IL-6 (c), and IL-10 (d) were measured as described in Material and Methods. Total
number of cells in peritoneal exudates was not diﬀerent among the groups (data not shown). Data are presented as mean± SEM (n = 5–10).
The CD + n6 group had just 5 samples up to the detection limit in the TNF-α assay. Two-way ANOVA and Bonferroni post-test were used
for statistical analysis. All LPS stimulated conditions were diﬀerent from unstimulated; ∗P < 0.05 versus CD with LPS; #P < 0.05 versus
CD + n6 with LPS; ◦P < 0.05 versus HFD with LPS.
This condition results in enhanced inflammatory response,
which stimulates the production of cytokines by adipose tis-
sue [45]. Moreover, in obesity, increased lipotoxicity caused
by high nonesterified fatty acids (NEFA) available, and
triacylglycerol content leads to an increase in inflammatory
markers and cytokine production in multiple organs [46,
47]. NEFA increases inflammatory response by activating
TLR-4 [48]. HFD increased inflammatory response in
macrophages, showing high content of IL-6, TNF-α, and
NO, and low content of IL-10 (anti-inflammatory cytokine)
when compared to the control group. In peripheral tissues,
IL-6 content was increased in the liver and gastrocne-
mius muscle whereas IL-10 content was decreased in liver
and retroperitoneal adipose tissue. Adipose tissue showed
increased production of leptin in the HFD and HFD +
n6 groups, compared with mice fed with control diet, and
resistin was reduced in the HFD + n6 group compared
with CD + n6, in epididymal adipose tissue. Whereas in
retroperitoneal adipose tissue, IL-6 was elevated in the HFD
and CD + n6 groups compared with CD, IL-10 was reduced
Journal of Biomedicine and Biotechnology 7
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Figure 3: Tissue cytokine concentrations of TNFα (a), IL6 (b), and IL10 (c) in adipose tissue (retroperitoneal), liver, and gastrocnemius
skeletal muscle from mice treated with control diet (CD) or high-fat diet (HFD), supplemented or not with sunflower oil (rich in n-6
fatty acids). Oral supplementation with n-6 (2 g/Kg body weight, three times a week, gavage) or water started four weeks before HFD and
continued until the end of experiment. Animals were feed with HFD or CD for eight weeks. Cytokines were measured in tissue homogenate.
Values are expressed as pg/mg protein. Mean ± SEM (n = 4–6). The statistical analysis was performed using two-way ANOVA with
Bonferroni post tests. ∗P < 0.05 when compared with CD; #P < 0.05 when compared with CD + n6.
in the HFD and CD + n6, and adiponectin was reduced
only in CD + n6. These results showed the inflammatory
characteristics the sunflower oil supplementation and the
high fatty diet fed.
Our results showed that sunflower oil supplementation
causes a clear pro-inflammatory response inmice fed on con-
trol diet and it does not have additive or prophylactic eﬀects
in mice fed on HFD. Fatty acid eﬀects on immune system
have been studied since 1970’s decade [49]. Linoleic acid is
an essential fatty acid that leads to inflammatory response by
increasing arachidonic acid production, a fatty acid related to
elevated pro-inflammatory mediator generation [50]. High
intake of linoleic acid has been associated to the development
of chronic diseases in several studies [51, 52]. However, few
studies have been carried out on the direct eﬀect of this fatty
acid on inflammatory markers [53].
In conclusion, our results showed that sunflower oil sup-
plementation has pro-inflammatory eﬀects in macrophages
and insulin-sensitive peripheral tissues and induced insulin
resistance in vivo and in vitro. These eﬀects were demon-
strated in mice fed a balanced diet and pronounced in mice
fed a HFD. Interestingly, sunflower oil supplementation par-
tially prevented the dislipidemia found in mice submitted to
HFD, but it did not improve or even worsened inflammatory
state and insulin resistance induced by this diet.
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